文献速递糖尿病

共同设计新临床路径以支持西澳大利亚早期1型糖尿病患儿家庭

Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia.
PubMed 文献 · Diabetologia · 2026-02-03

本研究采用经验式共同设计(EBCD)方法,分三阶段历时12个月,通过社区对话、焦点小组和联合工作坊,与1型糖尿病社区成员及医护人员共同开发了针对西澳大利亚早期(症状前)1型糖尿病患儿家庭的新型临床路径。识别出的关键需求包括教育、不确定性管理支持、疾病修饰疗法和临床试验信息,最终路径整合了这些优先事项。

要点

  • 早期1型糖尿病患儿家庭缺乏获取支持和教育的临床路径。
  • 共同设计识别出教育、心理支持和临床试验信息三大核心需求。
  • 新型临床路径基于EBCD方法开发,强调灵活服务模式和早期转介。

核心结论

  • 应用EBCD方法成功开发了针对西澳大利亚早期1型糖尿病患儿家庭需求的新临床路径。

研究设计与样本

  • 采用经验式共同设计(EBCD)方法,分三阶段连续12个月进行。
  • 阶段1和2分别开展社区对话和焦点小组,阶段3为联合工作坊。
  • 阶段1有16名社区成员和36名医护人员参与,阶段2有7名社区成员和11名医护人员参与,阶段3有3名社区成员和3名医护人员参与。

主要发现

  • 阶段1识别出三大关键类别:教育需求、不确定性的支持与管理策略需求、疾病修饰疗法和临床试验信息需求。
  • 阶段2识别出四项关键优先事项:获得擅长不确定性管理的医护人员、灵活的服务模式(远程/面对面)、早期转介至相关临床试验、可靠且最新的资源。
  • 阶段3对原型路径提供反馈并整合到最终版本。

临床怎么用

  • 临床路径应包含针对家庭的教育资源,帮助管理不确定性。
  • 提供灵活的服务模式,包括远程医疗和面对面服务。
  • 早期转介至相关临床试验,并提供可靠且最新的资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Children with early-stage (pre-symptomatic) type 1 diabetes are currently identified primarily via research-based screening programmes in Australia. Once identified, families live with the knowledge that their child has an increased chance of developing symptomatic, lifelong, insulin-requiring type 1 diabetes but have no specific clinical pathway available to them in Western Australia (WA) for accessing tailored support or education. This project aimed to co-design a new clinical pathway to address this unmet need. METHODS: Experience-based co-design (EBCD) methodology was applied, comprising three phases undertaken consecutively over 12 months. Recruitment for each phase was via open invitation with voluntary participation. Phases 1 and 2 involved facilitated community conversations and focus groups conducted separately for type 1 diabetes community members and healthcare professionals (HCPs). Data from these phases were analysed using deductive and inductive content analysis to identify key categories of information and a prototype clinical pathway was developed incorporating these. For phase 3, a combined workshop was held with all stakeholders to obtain feedback on the prototype, and refine it accordingly. RESULTS: In phase 1, 16 community members (people living with type 1 diabetes, families whose child or children had been screened for type 1 diabetes) and 36 HCPs (doctors, nurse educators, social workers, dietitians, a mental health nurse and administrative staff from Perth Children's Hospital) participated in separate community conversations. The following three key categories were identified: (1) the need for education; (2) the need for support and strategies for managing uncertainty; and (3) the need for information on disease-modifying therapies and access to clinical trials. In phase 2, seven community members and 11 HCPs participated in separate focus groups. The following key priorities were identified: (1) the need for access to HCPs skilled in supporting patients to manage uncertainty; (2) the need for flexibility in delivery modes (telehealth/in-person); (3) the need for early referral to relevant clinical trials; and (4) the need for reliable and up-to-date resources. In phase 3, three community members and three HCPs attended a combined workshop to provide feedback on a prototype clinical pathway and their feedback was incorporated into a final version. CONCLUSIONS/INTERPRETATION: Application of EBCD methodology enabled the development of a new clinical pathway tailored to the needs of WA families with a child living with early-stage type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Black SKP, Tully A, Davis EA, et al. Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia. Diabetologia. 2026. PMID: 41634173. doi:10.1007/s00125-026-06668-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。